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eafness is a hearing impairment that can be as a result of both genetic and environmental factors, and it is estimated that approximately 1 out 1000 children in the United States only are affected by it with half of these cases are due to genetic factors [1] . Deafness comes in various levels (moderate to severe) and has different types such as syndromic (25%), in which deafness is associated with other abnormalities in the body like blindness for example, and non-syndromic (75%), in which deafness is not accompanied with such symptoms [2] . Most of the genetic factors that contribute to hearing loss are caused by various mutations in the gene GJB2, which is also known as Gap Junction Beta 2 and it is found in chromosome 13, and mainly expressed in inner ear and skin. This important gene encodes for many gap junction proteins such as connexin 26, connexin 30, connexin 43, and so on [3] .
Furthermore, they are a group of membrane proteins whose main function is to facilitate the movement of certain ions, molecules, or even messengers that cannot pass through the hydrophobic part of the plasma membrane [4] . Among the various types of connexin proteins, mutations in connexin 26 (Cx26) was found to be most causing cases of deafness, especially for non-syndromic that are inherited by autosomal recessive nature, and which accounts for 70% of the cases [5] . Moreover, connexin 26 has an important function in the K + homeostasis inside the cochlea in the inner ear, and which part of the hearing process [6] . In this short review, we are going to discuss further the role of GJB2 mutations and how it leads to hearing impairment.
The GJB2 gene, cx2, and the hearing process
The GJB2 gene was the first gene to be identified in non-syndromic hearing impairment, and this suggests its importance in the coding of connexin 26. It is the main gap junction protein in regu- Fig. 1 [9] A B lating K + homeostasis during the normal function of hearing process, and which its mutations are responsible for most deafness cases [7] . Moreover, gap junction beta 2 is found in the long arms of chromosome 13 in positions 11 and 12, and has a length of 5.5 kilobases. This gene also has two exons, but only one of them, exon 2, codes for Cx26. The coding region has about 681 base pairs and the mRNA, which translates into connexin 26 protein having 226 amino acids, has a length of 2.4 kilobases [8] .
When sound waves are collected by the outer ear and move through the inner canal, they hit the eardrum which has three connected bones called ossicles, and their function is to conduct vibrations to a snail shell-like structure called cochlea, found in the inner ear [9, 10] . The organ of Corti, which found inside the cochlea, contains hair cells which sensors the vibrations accompanied by the movement a fluid called 'Endolymph' [11] . As it moves the tiny hairs back and forth causing the influx of potassium ions into them through connexin 26 gap junctions located on stereo cilia of the hair cells [11] . Afterwards, the influx of potassium ions inside the hair cells generates an electrical impulse by depolarization as illustrated in Fig. 1 , which is eventually sent to the auditory nerve and thus the brain interprets as sound [9, 10] .
connexin 26 protein
Connexin 26 (Cx26) protein is known as a gap junction protein. It is encoded by a gene called GJB2 gene. The mutation in GJB2 gene is the most common cause of congenital sensorineural hearing loss, which accounts for 10% of all childhood hearing loss and about 20% of genetically hearing loss [12] . These percentages show the huge effect of this ge-netic mutation in GJB2 gene. To find out how this mutation influences the protein structure, it is important to know its location and biological function.
Six connexin proteins are assembled together to form a connexon, which is also known as connexin hemichannel [13] . Two connexons from different cells will form a pore of a gap junction between the cytoplasm of the adjacent cells. This channel is responsible for the flow of ions and signaling molecules in a bidirectional flow [13] .
Protein Cx26 is composed of four transmembrane helices (from TM1 to TM4), as well as two extracellular loops (E1 & E2), functioning as the domains of this protein [14] . These play a huge role in the interhemichannel interactions of the connexons, where the E1 and E2 complex of one hemichannel would interact with the E1 and E2 complex of the other hemichannel, as shown in Fig. 2 [15] . There is also an intracellular loop, a cytoplasmic N-terminal helix and a cytoplasmic C-terminus [14] .
The connexin protein is composed of six conserved cysteine residues that would form three intramolecular disulfide bridges between E1 and E2, which contributes to the stabilization of the extracellular region structure [15] . Each extracellular domain of the connexin protein, which are the E1 and E2 have three specific cysteine residues which are highly preserved in all connexins [16] . They form the intramolecular disulfide bridges between the cysteine residues. The disulfide bonds of the residual cysteine are between 53 and 180, 60 and 174, and also between 64 and 169 [17] . Studies on other proteins have shown that a substitution of cysteine residues would result in the destabilization of the protein structure [16] . This clearly shows the importance of sulfide bonds in maintaining the stability of the protein structure (Fig. 3, D) .
mutations in the GJB2 gene
As mentioned earlier, 50% of hearing impairment cases are caused by genetic factors and most of them are due to mutations in the GJB2 gene. Because GJB2 codes for the instructions of making the protein Cx26, any changes in its nucleotide sequence might either result in a change of amino acids or deleting some of them contributing to the translation of a connexin 26 with an abnormal structure [18] . This irregular structure of the protein, whether it is incomplete or lost an essential bond that connects it with other monomers, it will surely lead it to be a faulty protein as all of its structure components plays a key role in stabilizing it, and so making able to carry its normal function [18] .
According to recent research, the most common connexin 26 mutation is 35delG, and it is a frame shift mutation that involves the deletion of Guanine base at position 35, causing in a shifting of the sequence, and thus resulting in TGA, a premature stop codon. Consequently, the coding sequence is terminated resulting in a shortened Cx26 protein [18] .
Another important mutation that is worth considering is Cys169Tyr. This is a missense mutation, which also is a point mutation where one nucleotide change would lead to a codon that codes for a different amino acid [19] . Correspondingly, in the codon TGC that codes for the amino acid cysteine at position 167, in the protein sequence of 226 amino acids, the mutation involves the switch of nitroge- nous base Guanine to Adenine, which consequently lead to the translation of tyrosine instead of cysteine as presented in Fig. 3 , A-C. Although the translation of protein structure is completed, the resulting protein has an abnormal structure of the extracellular domain E2 [17] . This mutation occurs in a highly conserved region, which affects one of the three cysteine residues responsible for disulfide bonds, which are extremely important for the connexon-connexon interaction. These as well stabilize the three-dimensional structure between the extracellular domains E1 and E2 of the protein connexin 26 [19] .
Cys169Tyr results in the destruction of a third disulfide bridge between cysteine residues 64 and 169 in the protein complex as shown in Fig. 3 , E [17] . This leads to the alteration of the three-dimensional structure of the whole connexin 26 molecule [19] . Consequently, the inhibition of the interactions between connexons of neighboring cells would occur as well as proper anchoring of connexions in the membrane [20] . Accordingly, the interactions between the cells are affected due to the changes occurring in the connexin protein structures [19] . Therefore, the exchange of low-molecular substances can no longer occur, as well as the regulation of the potassium ions homeostasis. This will hinder other processes in the inner ear and would eventually result in hearing loss [19, 20] .
future perspectives
In order to treat this condition, conducting further research on using interference RNA and gene therapy is highly recommended. According to scien tific literature, this was successfully attempted on transgenic mice and it has resulted in promising results [21] . Using small interference RNA mechanism, the target mRNA, Cys169Tyr Gjb2 in this case is degraded in the cytoplasm after transcription and so down regulating the gene expression [22] . The viral packaging and delivery of miRNA to Gjb2 Cys169Tyr human embryos would result in long-term silencing of the Cys169Tyr genes. In addition, the best proposed vector is "bovine adeno associated virus'', which is a single stranded DNA virus and has been shown to be very efficient in gene transfer, as well as relatively safe for causing no cytotoxicity according to previous work done by researchers [21] . The BAA viruses could be then injected to the human embryonic cells in the uterus through microinjec tions methods at suitable time (Before the cochlea develops). Finally, the expression of the genes can be assessed using western blots and the newborn hearing processes using 'Auditory brainstem responses' [21, 22] . For this reason, advanced research on orphan diseases such as inherited deafness due to GJB2 mutations using gene therapy and other molecular techniques is highly encouraged.
In conclusion, the proper function of the connexin 26 protein can be achieved thanks to the proper bonding of the three disulfide bridges at the cysteine residues 53 and 180, 60 and 174, in addition to 64 and 169. These cysteine residues are crucial in maintaining the stability of the protein structure. When the missense mutation in the GJB2 gene occurs, the cysteine residue in position 169 is replaced by a tyrosine, resulting in the loss of one disulfide bridge that is binding two connexons. Since the binding happens between the domains E1 and E2 of the connexons, no gap junction would be formed, where the potassium ions can move and contribute to the hearing process. The loss of this crucial biological function will result in deafness, which is a serious health problem that is affects many individuals, and can be treated using gene therapy in near future.
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Мутації гена GJB2 (Gap Junction Beta 2) є однією з головних причин спадкового пору-шення слуху. Цей ген кодує різні протеїни щі-линних контактів, зокрема конексину 26 (Cx26), який сприяє гомеостазу K + всередині равлика внутрішнього вуха. Мутації GJB2 також вияв-лено у разі несиндромальної глухоти (75% ви-падків), яка не супроводжується іншими анома-ліями в організмі. Cx26 складається з чотирьох трансмембранних спіралей і двох позаклітин-них петель, в кожній з яких є три специфічних, консервативних залишки цистеїну, зв'язаних внутрішньомолекулярними дисульфідними містками. Мутації 35delG і Cys169Tyr є найпоши-ренішими мутаціями GJB2. Перша призводить до скорочення протеїну Cx26 через переривання послідовності, що кодує, а друга -до дестабі-лізації структури протеїну через пошкодження одного із трьох залишків цистеїну. В цьому ко-роткому огляді надано додаткові дані про те, як ці два типи мутацій призводять до втрати слуху. К л ю ч о в і с л о в а: Gap Junction Beta 2 (GJB2) ген, конексин 26 (Cx26), несиндромальна форма, 35delG, Cys169Tyr, спадкова туговухість.
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Мутации гена GJB2 (Gap Junction Beta 2) являются одной из главных причин наслед-ственного нарушения слуха. Этот ген кодирует различные протеины щелевых контактов, в част-ности коннексин 26 (Cx26), способствующий гомеостазу K + внутри улитки внутреннего уха. Мутации GJB2 также выявлены при несиндро-мальной тугоухости (в 75% случаев), которая не сопровождается другими аномалиями в организ-ме. Cx26 состоит из четырех трансмембранных спиралей и двух внеклеточных петель, в каждой из которых имеется три специфических, консер-вативных остатка цистеина, связанных внутри-молекулярными дисульфидными мостиками. Мутации 35delG и Cys169Tyr являются наиболее распространенными мутациями GJB2. Первая приводит к укороченному протеину Cx26 из-за прерывания кодирующей последовательности, а вторая -к дестабилизации его структуры из-за повреждения одного из трех остатков цис теина. В этом коротком обзоре представлены дополни-тельные данные о том как эти два типа мутаций приводят к потере слуха. К л ю ч е в ы е с л о в а: Gap Junction Beta 2 (GJB2) ген, коннексин 26 (Cx26), несиндромаль-ная форма, 35delG, Cys169Tyr, наследственная тугоухость.
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